<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412017001200839</article-id>
<article-id pub-id-type="doi">10.24245/gom.v85i12.1552</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Endometrioma con elevación inusual de CA-19.9. Reporte de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Endometrioma with an unusual CA-19.9 elevation. A case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez-Ramírez]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-Rioja]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Delgado-Amador]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soriano-Jiménez]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Recio-López]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medina-Jiménez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguayo-González]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Nacional de Perinatología Isidro Espinosa de los Reyes  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Nacional de Perinatología Isidro Espinosa de los Reyes  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Nacional de Perinatología Isidro Espinosa de los Reyes  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
</aff>
<aff id="Af4">
<institution><![CDATA[,Instituto Nacional de Perinatología Isidro Espinosa de los Reyes  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Nacional de Perinatología Isidro Espinosa de los Reyes  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
</aff>
<aff id="Af6">
<institution><![CDATA[,Instituto Nacional de Perinatología Isidro Espinosa de los Reyes  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2017</year>
</pub-date>
<volume>85</volume>
<numero>12</numero>
<fpage>839</fpage>
<lpage>845</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412017001200839&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412017001200839&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412017001200839&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes: la prueba diagnóstica de referencia para endometriosis es la visualización de focos endometriósicos en un procedimiento quirúrgico. Los valores de CA-125 &gt; 35 UI/mL y de CA-19.9 &gt; 37 UI/mL sugieren endometriosis o tumores de ovario (teratomas, endometriomas y mucinosos). Los valores de CA-19.9 &gt; 300 UI/mL tienen un valor predictivo positivo mayor de 90% para cáncer de páncreas.  Caso clínico:  paciente de 32 años de edad, con infertilidad primaria de 10 años, tumoración compleja en el ovario derecho de 209 cc y en el ovario izquierdo de 14.81 cc, con CA-19.9 de 2,920 UI/mL y CA-125 de 142.37 UI/mL. Por tomografía y panendoscopia se descartó la posibilidad de malignidad en el aparato gastrointestinal. En la laparotomía exploradora, protocolizada para tumor de ovario, se encontró un tumor de 10 x 8.0 cm en el ovario derecho y uno de 3.0 x 2.0 cm en el izquierdo. El reporte de patología fue de quistes endometriósicos, sin malignidad coexistente. En el seguimiento a los 40 días se encontró un CA-19.9 de 41.38 U/mL y a los 60 días logró un embarazo espontáneo.  Conclusiones: los marcadores tumorales se utilizan para descartar algún proceso maligno en el ovario. Se carece de pruebas suficientes para recomendarlos rutinariamente para diagnosticar endometriosis. Cuando inusualmente sus valores se encuentran por encima del punto de corte, es importante descartar cualquier malignidad en el aparato gastrointestinal. Se recomienda asumir el tratamiento de estas pacientes con un equipo multidisciplinario.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background: Endometriosis is the presence of ectopic non-neoplastic endometrial tissue. The gold standard diagnosis is a visual inspection by laparoscopy. A CA-125 &gt;35 IU/mL and a CA-19.9 &gt;37 IU/mL have been present in endometriosis and ovarian tumors (teratomas, endometriomas or mucinous). However, an elevation &gt;300 IU/mL have a positive predictive value &gt;90% for pancreatic cancer.  Case report: 32-year-old female, with 10-year primary infertility. With a complex tumor in the right ovary of 209cc and in the left one of 14.81cc. The CA-19.9 was at 2,920 IU/mL and the CA-125 at 142.37 IU/mL. In which have ruled out gastrointestinal malignancy with tomography and panendoscopy. A laparotomy exploratory was performed, finding a tumor of 10x8.0cm in the right ovary and 3.0x2.0cm in the left one. The pathology report was of endometriosis cysts, with no coexisting malignancy. At follow-up at 40 days a CA-19.9 of 41.38 IU/mL was found and at 60 days achieved a spontaneous pregnancy.  Conclusions: Tumor biomarkers are generally used to rule out malignant ovary pathology. There is insufficient evidence to recommend its routine use to diagnose endometriosis. However, when they are unusually above the cut-off point, it is important to specifically rule out gastrointestinal malignancy, working in a multidisciplinary way.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[endometriosis]]></kwd>
<kwd lng="es"><![CDATA[CA-19.9 elevado]]></kwd>
<kwd lng="en"><![CDATA[Endometriosis]]></kwd>
<kwd lng="en"><![CDATA[CA-19.9 elevated]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunselman]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Vermeulen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESHRE guideline management of women with endometriosis]]></article-title>
<source><![CDATA[Hum Reprod]]></source>
<year>2014</year>
<volume>29</volume>
<page-range>400-12</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Kendziorski]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis where are we and where are we going?]]></article-title>
<source><![CDATA[Reproduction]]></source>
<year>2016</year>
<volume>152</volume>
<page-range>63-78</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benagianoa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brosensc]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Lippi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The History of Endometriosis]]></article-title>
<source><![CDATA[Gynecol Obstet Invest]]></source>
<year>2014</year>
<volume>78</volume>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parazzini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Esposito]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tozzi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of endometriosis and its comorbidities]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2016</year>
<page-range>S0301-2115:30172-30175</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Priorities for endometriosis research recommendations from an international consensus workshop]]></article-title>
<collab>D&amp;aposHooghe TM.Fazleabas A</collab>
<source><![CDATA[Reprod Sci]]></source>
<year>2009</year>
<volume>16</volume>
<page-range>335-46</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnett]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Banks]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Decherney]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis and Fertility Preservation]]></article-title>
<source><![CDATA[Clin Obstet Gynecol]]></source>
<year>2017</year>
<volume>60</volume>
<page-range>517-23</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Decherney]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fertility and Endometriosis]]></article-title>
<source><![CDATA[Clin Obstet Gynecol]]></source>
<year>2017</year>
<volume>60</volume>
<page-range>497-502</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adamson]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hummelshoj]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Creating solutions in endometriosis global collaboration through the World Endometriosis Research Foundation]]></article-title>
<source><![CDATA[J of Endometriosis]]></source>
<year>2010</year>
<volume>2</volume>
<page-range>3-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simoens]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hummelshoj]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dunselman]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis cost assessment (the EndoCost study) a cost-of-illness study protocol]]></article-title>
<source><![CDATA[Gynecol Obstet Invest]]></source>
<year>2011</year>
<volume>71</volume>
<page-range>170-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Donnez]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Guzick]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revised American Society for Reproductive Medicine classification of endometriosis 1996]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>1997</year>
<volume>67</volume>
<page-range>817-21</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vercellini]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Viganò]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Somigliana]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis pathogenesis and treatment]]></article-title>
<source><![CDATA[Nat Rev Endocrinol]]></source>
<year>2014</year>
<volume>10</volume>
<page-range>261-75</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yeung]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The laparoscopic management of endometriosis in patients with pelvic pain]]></article-title>
<source><![CDATA[Obstet Gynecol Clin North Am]]></source>
<year>2014</year>
<volume>41</volume>
<page-range>371-83</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flyckt]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Falcone]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of endometriosis in patients with chronic pelvic pain]]></article-title>
<source><![CDATA[Semin Reprod Med]]></source>
<year>2017</year>
<volume>35</volume>
<page-range>54-64</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rizk]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Lotfy]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recurrence of endometriosis after hysterectomy]]></article-title>
<source><![CDATA[Facts Views Vis Obgyn]]></source>
<year>2014</year>
<volume>6</volume>
<page-range>219-27</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vercellini]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vigano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Somigliana]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis pathogenesis and treatment]]></article-title>
<source><![CDATA[Nat Rev Endocrinol]]></source>
<year>2013</year>
<volume>10</volume>
<page-range>261-75</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tayade]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarkers in endometriosis challenges and opportunities]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2017</year>
<volume>107</volume>
<page-range>523-32</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monforte]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Poncelet]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surgical management of endometriosis]]></article-title>
<source><![CDATA[Minerva Ginecol]]></source>
<year>2013</year>
<volume>65</volume>
<page-range>113-23</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoyos]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Puscheck]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis and Imaging]]></article-title>
<source><![CDATA[Clin Obstet Gynecol]]></source>
<year>2017</year>
<volume>60</volume>
<page-range>503-16</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tayade]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarkers in endometriosis challenges and opportunities]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2017</year>
<volume>107</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>523-32</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nisenblat]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[PMM]]></given-names>
</name>
<name>
<surname><![CDATA[Shaikh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blood biomarkers for the non-invasive diagnosis of endometriosis]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2016</year>
<volume>5</volume>
<page-range>1-654</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scarà]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bottoni]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Scatena]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CA 19-9 biochemical and clinical aspects]]></article-title>
<source><![CDATA[Adv Exp Med Biol]]></source>
<year>2015</year>
<volume>867</volume>
<page-range>247-60</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pyeon]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Ki]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abnormally high level of CA-19-9 in a benign ovarian cyst]]></article-title>
<source><![CDATA[Obstet Gynecol Sci]]></source>
<year>2015</year>
<volume>58</volume>
<page-range>530-2</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yap]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The clinical significance of elevated levels of serum CA 19-9]]></article-title>
<source><![CDATA[Med J Malaysia]]></source>
<year>2003</year>
<volume>58</volume>
<page-range>667-72</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Loosen]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Neumann]]></surname>
<given-names><![CDATA[UP]]></given-names>
</name>
<name>
<surname><![CDATA[Trautwein]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current and future biomarkers for pancreatic adenocarcinoma]]></article-title>
<source><![CDATA[Tumour Biol]]></source>
<year>2017</year>
<volume>39</volume>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Michl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Laubender]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy]]></article-title>
<source><![CDATA[Tumour Biol]]></source>
<year>2014</year>
<volume>35</volume>
<page-range>10121-7</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Basso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Plebani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ca 19-9 HandLe with care]]></article-title>
<source><![CDATA[Clin Chem Lab Med]]></source>
<year>2013</year>
<volume>51</volume>
<page-range>1369-83</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milena]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Vaclav]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometriosis-Search for biomarkers]]></article-title>
<source><![CDATA[Am J Immunol]]></source>
<year>2016</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>43-8</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unusually High Serum Levels of CA 19-9 in an ovarian tumour malignant or benign?]]></article-title>
<source><![CDATA[J Clin Diagn Res]]></source>
<year>2017</year>
<volume>11</volume>
<page-range>8-10</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakagawa]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Koda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nitta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reactivity of CA 19 9 and CA 125 in histological subtypes of epithelian ovarian tumors and ovarian endometriosis]]></article-title>
<source><![CDATA[Acta Med Okayama]]></source>
<year>2015</year>
<volume>69</volume>
<page-range>227-35</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AL-Tai]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[AL-Hadithi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Abdulsalam]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ca 19-9 versus CA 125 in endometriosis]]></article-title>
<source><![CDATA[IOSR-JDMS]]></source>
<year>2014</year>
<volume>13</volume>
<page-range>27-30</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Archbold]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum CA19 9 levels are commonly elevated in primary ovarian mucinous tumors but cannot be used to predict the histological subtype]]></article-title>
<source><![CDATA[J Clin Pathol]]></source>
<year>2010</year>
<volume>63</volume>
<page-range>169-73</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Kyung]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumours a matched case-control study]]></article-title>
<source><![CDATA[Med Sci Monit]]></source>
<year>2014</year>
<volume>20</volume>
<page-range>1334-9</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurata]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sasaki]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kase]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometrioma]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2002</year>
<volume>105</volume>
<page-range>75-6</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takemori]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sugimura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ovarian chocolate cyst with markedly elevated serum CA19-9 level A case report]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>1991</year>
<volume>42</volume>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dai]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas]]></article-title>
<source><![CDATA[Clin Chim Acta]]></source>
<year>2015</year>
<volume>450</volume>
<page-range>362-5</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kataoka]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hoshiai]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma]]></article-title>
<source><![CDATA[J Obstet Gynaecol Res]]></source>
<year>2012</year>
<volume>38</volume>
<page-range>1071-6</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ye]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Komatsu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>1994</year>
<volume>52</volume>
<page-range>267-71</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hiroshi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Shogo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis]]></article-title>
<collab>Haruki N et al</collab>
<source><![CDATA[Mol Med Rep]]></source>
<year>2014</year>
<volume>9</volume>
<page-range>1483-505</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cakmak]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implantation failure molecular mechanisms and clinical treatment]]></article-title>
<source><![CDATA[Hum Reprod Update]]></source>
<year>2011</year>
<volume>17</volume>
<page-range>242-53</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Strawn]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Basir]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2007</year>
<volume>87</volume>
<page-range>24-32</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yotova]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Do]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gaba]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2017</year>
<volume>26</volume>
<page-range>1-32</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
